BioCentury | Sep 5, 2019
Financial News

Sept. 5 Financial Quick Takes: Zealand raises cash as it readies NDA; plus Bellus, Aerie, LNC, Veralox and Sigrid

Ahead of NDA submission, Zealand raising cash Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) is raising DKK559.6 million ($82.4 million) via a private placement and directed share issue to existing investor Van Herk Investments. Zealand will sell...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

Seventure Partners announced the first close of its second microbiome-focused health fund and is targeting a €200 million ($226.9 million) final raise. Seventure's Isabelle de Cremoux said the VC has raised more than half of...
BioCentury | Jul 13, 2015
Finance

Seventure's microbiome plays

Seventure Partners' latest investment from its Health for Life Capital fund aims to harness the precision of CRISPR technology to preferentially eliminate harmful bacteria from the microbiome. Seventure was the sole investor in Eligo Bioscience...
BioCentury | May 5, 2014
Financial News

LNC completes venture financing

Laboratoires Nutrition et Cardiometabolisme , Bordeaux, France Business: Endocrine/Metabolic, Nutraceuticals Date completed: 4/28/14 Type: Venture financing Raised: €1.2 million ($1.7 million) Investor: Seventure Partners WIR Staff...
Items per page:
1 - 4 of 4
BioCentury | Sep 5, 2019
Financial News

Sept. 5 Financial Quick Takes: Zealand raises cash as it readies NDA; plus Bellus, Aerie, LNC, Veralox and Sigrid

Ahead of NDA submission, Zealand raising cash Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) is raising DKK559.6 million ($82.4 million) via a private placement and directed share issue to existing investor Van Herk Investments. Zealand will sell...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

Seventure Partners announced the first close of its second microbiome-focused health fund and is targeting a €200 million ($226.9 million) final raise. Seventure's Isabelle de Cremoux said the VC has raised more than half of...
BioCentury | Jul 13, 2015
Finance

Seventure's microbiome plays

Seventure Partners' latest investment from its Health for Life Capital fund aims to harness the precision of CRISPR technology to preferentially eliminate harmful bacteria from the microbiome. Seventure was the sole investor in Eligo Bioscience...
BioCentury | May 5, 2014
Financial News

LNC completes venture financing

Laboratoires Nutrition et Cardiometabolisme , Bordeaux, France Business: Endocrine/Metabolic, Nutraceuticals Date completed: 4/28/14 Type: Venture financing Raised: €1.2 million ($1.7 million) Investor: Seventure Partners WIR Staff...
Items per page:
1 - 4 of 4